AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35674835 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (180-mg loading dose)
Number of subjects: 49
Study 35674835 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600-mg loading dose)
Number of subjects: 49
Study 34132753 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletonized internal mammary artery harvesting
Number of subjects: 1002
Study 34132753 — intervention group
Group type: COMPARATOR
Intervention: Pedicled internal mammary artery harvesting
Number of subjects: 1002
Study 32002547 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fraction stereotactic radiosurgery (SRS) with 5-mm margins at 40 Gy
Number of subjects: 30
Study 32002547 — intervention group
Group type: COMPARATOR
Intervention: 5-fraction stereotactic radiosurgery (SRS) with 5-mm margins at 25, 30, 35 Gy
Number of subjects: 30
Study 35148516 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg oral tamsulosin for 5 days preoperatively and 2 days postoperatively
Number of subjects: 610
Study 35148516 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 5 days preoperatively and 2 days postoperatively
Number of subjects: 610
Study 33573896 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Periodontal scaling once a month
Number of subjects: 48
Study 33573896 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Periodontal scaling once every 3 months
Number of subjects: 48
Study 33573896 — intervention group
Group type: COMPARATOR
Intervention: Group C: Periodontal scaling once every 6 months
Number of subjects: 48
Study 32955832 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT-A
Number of subjects: 60
Study 32955832 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT-AR
Number of subjects: 60
Study 32955832 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 35014965 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (n=191)
Number of subjects: 382
Study 35014965 — intervention group
Group type: COMPARATOR
Intervention: Validation group (n=191)
Number of subjects: 382
Study 32959584 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST 36) in group A
Number of subjects: 63
Study 32959584 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at Zusanli (ST 36) and Zhongwan (CV 12) in group B
Number of subjects: 63
Study 36322937 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose hydroxyurea (20 mg/kg per day)
Number of subjects: 101
Study 36322937 — intervention group
Group type: COMPARATOR
Intervention: Low-dose hydroxyurea (10 mg/kg per day)
Number of subjects: 101
Study 35724939 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable resin composite (Tetric Evo Flow)
Number of subjects: 34
Study 35724939 — intervention group
Group type: COMPARATOR
Intervention: Sealant material (Helioseal F)
Number of subjects: 34
Study 35724939 — intervention group
Group type: EXPERIMENTAL
Intervention: Both materials (Tetric Evo Flow and Helioseal F)
Number of subjects: 34
Study 32041658 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine hydrobromide 4-6 µg/kg
Number of subjects: 40
Study 32041658 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrronium bromide 4 µg/kg (active placebo)
Number of subjects: 40
Study 35033468 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 6932
Study 35033468 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 6932
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Unemployed mothers
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid eligible mothers
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Less educated mothers
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking mothers
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers providing less skin-to-skin care
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers delaying the decision to provide milk
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Minutes of skin-to-skin care
Number of subjects: 142
Study 33030992 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient maternal milk production
Number of subjects: 142
Study 33787833 — intervention group
Group type: EXPERIMENTAL
Intervention: Music system intervention used during nursing activities
Number of subjects: 18
Study 33787833 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music system intervention)
Number of subjects: 18
Study 32076866 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 80
Study 32076866 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% CHX
Number of subjects: 80
Study 32076866 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% essential oils (EO)
Number of subjects: 80
Study 32076866 — intervention group
Group type: COMPARATOR
Intervention: water
Number of subjects: 80
Study 32076866 — intervention group
Group type: EXPERIMENTAL
Intervention: essential oils (EO)
Number of subjects: 80
Study 35971150 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐cigarettes with 18 mg/ml nicotine
Number of subjects: 248
Study 35971150 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐cigarettes without nicotine
Number of subjects: 248
Study 35971150 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT
Number of subjects: 248
Study 33975901 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment maneuver followed by 5 cm H2O of PEEP (RM5 group)
Number of subjects: 192
Study 33975901 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment maneuver followed by 10 cm H2O of PEEP (RM10 group)
Number of subjects: 192
Study 33975901 — intervention group
Group type: COMPARATOR
Intervention: Volume control ventilation with 5 cm H2O of PEEP (control group)
Number of subjects: 192
Study 32780736 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed approach for identifying machine-interpretable topics using Linked Open Data (LOD).
Number of subjects: 1000000
Study 32780736 — intervention group
Group type: COMPARATOR
Intervention: Traditional words-list-based representations for topic identification.
Number of subjects: 1000000
Study 35182043 — intervention group
Group type: EXPERIMENTAL
Intervention: Deucravacitinib 12 mg
Number of subjects: 0
Study 35182043 — intervention group
Group type: EXPERIMENTAL
Intervention: Deucravacitinib 36 mg
Number of subjects: 0
Study 35182043 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 0
Study 35182043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33118927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTi), n = 72
Number of subjects: 145
Study 33118927 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control, n = 73
Number of subjects: 145
Study 35351238 — intervention group
Group type: EXPERIMENTAL
Intervention: Short regimen (including moxifloxacin and clofazimine)
Number of subjects: 282
Study 35671086 — intervention group
Group type: EXPERIMENTAL
Intervention: NRD.E1 at 40 mg/day
Number of subjects: 88
Study 35671086 — intervention group
Group type: EXPERIMENTAL
Intervention: NRD.E1 at 150 mg/day
Number of subjects: 88
Study 35671086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 35671086 — intervention group
Group type: EXPERIMENTAL
Intervention: NRD.E1
Number of subjects: 88
Study 33965188 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucovorin (LCV) following MTX
Number of subjects: 46
Study 33965188 — intervention group
Group type: COMPARATOR
Intervention: Historical controls (no LCV)
Number of subjects: 46
Study 32528172 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 1284
Study 32528172 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 1284
Study 32528172 — intervention group
Group type: EXPERIMENTAL
Intervention: Older children (boys and girls)
Number of subjects: 1284
Study 34996593 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent prophylactic face-mask noninvasive ventilation (NIV) for 6-8 hours per day
Number of subjects: 266
Study 34996593 — intervention group
Group type: COMPARATOR
Intervention: Usual postoperative care
Number of subjects: 266
Study 33548056 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support pre-treatment
Number of subjects: 2858
Study 33548056 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe lack of social support
Number of subjects: 2858
Study 36309984 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with Simvastatin and Ezetimibe
Number of subjects: 2029
Study 36309984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2029
Study 33649098 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (1 g) on days 1 and 15
Number of subjects: 74
Study 33649098 — intervention group
Group type: COMPARATOR
Intervention: Cyclic regimen with corticosteroids and cyclophosphamide
Number of subjects: 74
Study 36017205 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy
Number of subjects: 60
Study 36017205 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise (WBE)
Number of subjects: 60
Study 36017205 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-based exercise (LBE)
Number of subjects: 60
Study 33389614 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mammography and adjunctive ultrasound
Number of subjects: 0
Study 33389614 — intervention group
Group type: COMPARATOR
Intervention: Mammography alone
Number of subjects: 0
Study 32558226 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient monitoring
Number of subjects: 56
Study 32558226 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 56
Study 35517806 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocin supplementation (30 mg/day for 12 weeks)
Number of subjects: 46
Study 35517806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 33589246 — intervention group
Group type: EXPERIMENTAL
Intervention: OCHRA feedback
Number of subjects: 50
Study 33589246 — intervention group
Group type: COMPARATOR
Intervention: OSATS feedback
Number of subjects: 50
Study 34991056 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) at 10-30 mg/kg/day
Number of subjects: 42
Study 34991056 — intervention group
Group type: COMPARATOR
Intervention: Placebo (previous treatment)
Number of subjects: 42
Study 34055121 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 76
Study 34055121 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 76
Study 36106611 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteus Discover (PD) with TDF/FTC
Number of subjects: 100
Study 36106611 — intervention group
Group type: COMPARATOR
Intervention: TDF/FTC standard-of-care
Number of subjects: 100
Study 33512065 — intervention group
Group type: COMPARATOR
Intervention: KHK4083 (10 mg/kg, single intravenous dose)
Number of subjects: 36
Study 33512065 — intervention group
Group type: EXPERIMENTAL
Intervention: KHK4083 (multiple intravenous doses)
Number of subjects: 36
Study 36346336 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion management
Number of subjects: 0
Study 36398451 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI reporting intervention
Number of subjects: 9665
Study 36398451 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 round of BMI reporting
Number of subjects: 9665
Study 36398451 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 rounds of BMI reporting
Number of subjects: 9665
Study 33668058 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich (PROT) diet
Number of subjects: 163
Study 33668058 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate-rich (CARB) diet
Number of subjects: 163
Study 33668058 — intervention group
Group type: COMPARATOR
Intervention: Unsaturated fat-rich (UNSAT) diet
Number of subjects: 163
Study 35627807 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT)
Number of subjects: 40
Study 35627807 — intervention group
Group type: COMPARATOR
Intervention: Control (non-animal-related recreational activities)
Number of subjects: 40
Study 32912828 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based randomized intervention trial
Number of subjects: 0
Study 32912828 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for participation
Number of subjects: 0
Study 32912828 — intervention group
Group type: EXPERIMENTAL
Intervention: Final survey participation
Number of subjects: 0
Study 34031888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 40
Study 34031888 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 40
Study 34031888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34472756 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at 'ghost points' combined with acupoints selected by syndrome differentiation
Number of subjects: 124
Study 34472756 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation treatment
Number of subjects: 124
Study 33767376 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein regimen (18% energy intake as amino acids, targeting 4 g/kg/day)
Number of subjects: 71
Study 33767376 — intervention group
Group type: COMPARATOR
Intervention: Conventional regimen (12.5% energy intake as amino acids, targeting 3 g/kg/day)
Number of subjects: 71
Study 33767376 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein regimen
Number of subjects: 71
Study 33767376 — intervention group
Group type: COMPARATOR
Intervention: Conventional regimen
Number of subjects: 71
Study 33767376 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study 34461161 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose oral thiamine (one gram twice daily)
Number of subjects: 0
Study 34461161 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study 34729774 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus the interprofessional student-run medication review program (ISP)
Number of subjects: 216
Study 34729774 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 216
Study 36356395 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cognitive-behavioral intervention
Number of subjects: 159
Study 36356395 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-only expectancy challenge
Number of subjects: 159
Study 36356395 — intervention group
Group type: COMPARATOR
Intervention: Neutral reading (control) task
Number of subjects: 159
Study 34488269 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative therapy (once a week for 30 min over 6 weeks)
Number of subjects: 60
Study 34488269 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine clinical treatment)
Number of subjects: 60
Study 34488269 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative therapy
Number of subjects: 60
Study 34488269 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 32005202 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker recruitment (door-to-door)
Number of subjects: 31
Study 32005202 — intervention group
Group type: COMPARATOR
Intervention: Community health meetings
Number of subjects: 31
Study 32005202 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated package of cervical cancer screening and education
Number of subjects: 31
Study 35461689 — intervention group
Group type: EXPERIMENTAL
Intervention: MI3 algorithm (machine learning algorithm)
Number of subjects: 20761
Study 35166608 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment plus virtual reality exercises with the Nintendo Wii console (n=36)
Number of subjects: 73
Study 35166608 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy treatment (control group, n=37)
Number of subjects: 73
Study 33588078 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2000 IU daily)
Number of subjects: 666
Study 33588078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 666
Study 32639634 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (10 mg/kg daily)
Number of subjects: 111
Study 32639634 — intervention group
Group type: COMPARATOR
Intervention: Low dose (5 mg/kg daily)
Number of subjects: 111
Study 36303303 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored reproductive health promotion programme based on the Precaution Adoption Process Model (PAPM) over 8 weeks
Number of subjects: 60
Study 36303303 — intervention group
Group type: COMPARATOR
Intervention: Educational material
Number of subjects: 60
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 0.5 mg/kg ketamine followed by continuous infusion of 5 μg/kg/min (K1 group)
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 0.5 mg/kg ketamine followed by continuous infusion of 10 μg/kg/min (K2 group)
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 0.5 mg/kg ketamine followed by continuous infusion of 20 μg/kg/min (K3 group)
Number of subjects: 100
Study 32981056 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane alone (K0 group)
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: K2 and K3 groups compared to K1 group
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: K3 group compared to K2 group
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: K2 and K3 groups compared to K0 and K1 groups
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate and MAP after pneumoperitoneum
Number of subjects: 100
Study 32981056 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall haemodynamics during the study period
Number of subjects: 100
Study 32513228 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical treatment
Number of subjects: 422
Study 35591748 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational SMS ± additional support group (ESMS±S)
Number of subjects: 196
Study 35591748 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple SMS group
Number of subjects: 196
Study 35591748 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 196
Study 32891521 — intervention group
Group type: EXPERIMENTAL
Intervention: In-plane ultrasound guidance
Number of subjects: 84
Study 32891521 — intervention group
Group type: COMPARATOR
Intervention: Out-of-plane ultrasound guidance
Number of subjects: 84
Study 32453346 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace wellness program with financial incentives and paid time off for biometric screenings and health risk assessments.
Number of subjects: 4834
Study 32453346 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace wellness program
Number of subjects: 4834
Study 32453346 — intervention group
Group type: COMPARATOR
Intervention: Control group (no participation in wellness program)
Number of subjects: 4834
Study 35007748 — intervention group
Group type: EXPERIMENTAL
Intervention: Crimson duvet procedure (CDP) with microfracture treatment of the footprint
Number of subjects: 123
Study 35007748 — intervention group
Group type: COMPARATOR
Intervention: Control group with débridement of the footprint
Number of subjects: 123
Study 33243143 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus thuringiensis strains (tenebrionis 4AA1 carrying pBMB76 and kurstaki HD73 carrying pHT73)
Number of subjects: 684
Study 33243143 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed application of Bacillus thuringiensis strains (4AA1 + HD73)
Number of subjects: 684
Study 35090154 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppressive valacyclovir treatment for 1 year
Number of subjects: 400
Study 35090154 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 400
Study 33749386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical interventions targeting multiple mediators (not specified)
Number of subjects: 0
Study 33749386 — intervention group
Group type: EXPERIMENTAL
Intervention: G-computation method
Number of subjects: 0
Study 33749386 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-harm example from the Victorian Adolescent Health Cohort Study
Number of subjects: 0
Study 32814593 — intervention group
Group type: EXPERIMENTAL
Intervention: Holographic (HG) anatomic model
Number of subjects: 29
Study 32814593 — intervention group
Group type: COMPARATOR
Intervention: Didactic lecture (DL)
Number of subjects: 29
Study 32814593 — intervention group
Group type: COMPARATOR
Intervention: Computer module (CM)
Number of subjects: 29
Study 32831210 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT)
Number of subjects: 60
Study 32831210 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic Training (IKT)
Number of subjects: 60
Study 32831210 — intervention group
Group type: COMPARATOR
Intervention: Control Group (NCONTROL)
Number of subjects: 60
Study 33753652 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel combined with calcium hydroxide (CH + CHX) for 1 week
Number of subjects: 90
Study 33753652 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel combined with calcium hydroxide (CH + CHX) for 2 weeks
Number of subjects: 90
Study 33753652 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel combined with calcium hydroxide (CH + CHX) for 3 weeks
Number of subjects: 90
Study 36396065 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified weight loss program
Number of subjects: 228
Study 36396065 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory Control Training (ICT)
Number of subjects: 228
Study 36396065 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified weight loss program + ICT
Number of subjects: 228
Study 36396065 — intervention group
Group type: COMPARATOR
Intervention: Non-gamified weight loss program + Sham ICT
Number of subjects: 228
Study 33629100 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 1043